“showed a trend”

2 B) with regard to WT1 IgG Ab level in serous OC whereas patients with nonserous subtypes showed a trend to a poor clinical outcome correlated with high-WT1 IgG Ab level for PFS ( P = 0.059, Fig. 2 C).

In addition, although not statistically significant, the ETB group showed a trend toward a higher total gonadotropin dose ( P = 0.059) and a higher likelihood of female-related infertility factors ( P = 0.056).

Post hoc analysis showed a trend towards statistical difference between the LOT (2.20 μV ± 0.26) and middle ROI (2.99 μV ± 0.26) ( p = 0.059) and between the LOT and the ROT (3.19 μV ± 0.43) ( p = 0.065) but no difference between the middle ROI and the ROT ( p = 1).

As can be seen in Table 5 , in a main effects model of fear, effortful control only showed a trend toward relating to fearful temperament ( b = −.77, t = −2.03, p = .059).

Compared to younger subjects, older subjects reported less Impaired Control and Cognition and also showed a trend for more Blissful State ( p = 0.059).

We observed that, with respect to patients with baseline eGFR ≥ 60 mL/min/1.73 m 2 , those with AKI (low baseline eGFR and no history of CKD) showed a trend of an increased hazard ratio to reach the combined outcome ( p = 0.059), while those patients with both low eGFR and CKD had a significantly higher probability to develop the combined outcome ( p < 0.001) ( Table 4 ).

However, complex cataract classification showed a trend toward increased general anesthesia use (aOR=2.21; 95% CI, 0.93–4.93; p=0.059).

Between-group, post hoc t -tests on the reduction of movement-speed variability was significantly changed for the fast training group [ t (16) = −2.570, P = 0.021] and showed a trend for the slow group [ t (16) = −2.037, P = 0.059].

Changes in fasting glucose levels over the diet treatment period showed a trend toward a main effect of diet ( F = 3.84, p = 0.059; Fig. 1 I ).

Moreover, even though not reaching statistical significance, females showed a trend of higher odds of SARSCoV- 2 positivity [adjusted OR (95% CI): 1.108 (0.996-1.232), p=0.059], when compared to males.

The pre/post central gyri RSN showed a trend ( p = 0.059), while all other RSNs were not significant ( p > 0.428).

Body weight showed a trend in the same direction (ρ = −0.47, p = 0.059).

Low SMD showed a trend toward reduced OS (HR 0.49, 95% CI 0.23–1.03, p = 0.059), whereas low L3 SMI was significantly associated with shorter OS (HR 0.37, 95% CI 0.16–0.87, p = 0.023).

Hypertension was associated with nicotine abuse ( p = 0.034), hypercholesterolemia ( p = 0.0011), obesity ( p = 0.0022), history of vascular diseases ( p = 0.011), and showed a trend with diabetes ( p = 0.059) ( Figure 3 , Table 2 ).

Likelihood ratio testing confirmed that HER2DX metastatic score added significant prognostic information beyond ERBB2 for rwOS (χ2=10.944, p = 0.004) and showed a trend for rwPFS (χ2=5.673, p = 0.059).

Similar to the findings in all 64 patients, female patients showed a trend toward longer mPFS ( p = 0.059) and mOS ( p = 0.091).

The total number of above-threshold interregional correlations in the OPR group showed a trend-level increase compared to the STA group (χ2 = 3.559, z = 1.887, p = 0.059).

In the HBS group, BMD improved more significantly in the femur (P = 0.005) and showed a trend towards improvement in the spine (P = 0.059).

LMMs for repeated measures with AEA as the dependent variable showed a trend-level significant main effect of GROUP (F(1,93.7) = 3.65, p =.059, f 2 = 0.039) and TIME (F(1,52.0) = 3.05, p =.087, f 2 = 0.059), but no GROUP*TIME interaction effects (F(1,52.2) = 0.33, p =.566, f 2 = 0.006).

In addition, the absence of residual urine output was significantly associated with higher sleep disturbance scores ( p = 0.002), whereas the association with fatigue showed a trend toward statistical significance ( p = 0.059).

Furthermore, BDNF showed a trend (lacked statistical significance) to relate to longer MACE‐free survival ( p = 0.059).

CVST response time showed a trend toward improvement over the course of the study ( p = 0.059), but a learning effect cannot be excluded here.

The BPRS Negative Symptoms factor had a significant positive association (β = 0.467, p = 0.026), while Positive Symptoms showed a trend toward a positive relationship (β = 0.508, p = 0.059).

Interestingly, patients who had an advanced imaging at diagnosis showed a trend toward shorter TTP when compared to those who did not have an advanced imaging: 43.4 months (95% CI, 29.8–69.1) vs. 62.4 months (95% CI, 45.9–83.1; p = 0.059).

Overall survival also showed a trend favoring the dose-escalation group (54.9% vs 36.2%; P = .059).